Bristol-Myers

Extracted Attributes

Bristol Myers Squibb

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation (30% of 2025 revenues); nivolumab (Opdivo), used to treat certain types of cancer (21% of 2025 revenues); lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (6% of 2025 revenues); abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis (8% of 2025 revenues); pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma (6% of 2025 revenues); ipilimumab (Yervoy), to treat cancer (6% of 2025 revenues); and luspatercept (Reblozyl) for the treatment of anemia in beta thalassemia and myelodysplastic syndromes (5% of 2025 revenues). In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. BMS's primary research and development (R&D) sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey; Redwood City, California; and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts; Braine-l'Alleud, Belgium; Tokyo, Japan; Hyderabad; Bangalore, India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers).

Web Search Results

• Bristol-Myers Squibb Company | Business and Management | Research Starters | EBSCOhost

  Bristol-Myers Squibb, also known as BMS, is a multinational pharmaceutical and research company with facilities in countries around the world, including Belgium, France, Japan, Mexico, the Netherlands, and the United Kingdom, among others. The company’s headquarters is located in New York City. BMS lists its mission as “to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.” [...] RESEARCH STARTER # Bristol-Myers Squibb Company Bristol-Myers Squibb Company (BMS) is a multinational biopharmaceutical firm founded in 1887, with its corporate headquarters located in New York City. The company is focused on the research, development, manufacturing, and distribution of innovative medicines aimed at addressing serious diseases. BMS operates globally, with facilities in numerous countries, and is particularly recognized for its advancements in chemistry, pharmacy, and biology. Some of its well-known products include Abilify, Plavix, and Eliquis. [...] ## Full article ### Company information Date founded: 1887 Industry: Biopharmaceutical manufacturing, research, and sales. Corporate headquarters: Princeton, New Jersey Type: Public Bristol-Myers Squibb, also known as BMS, is a multinational pharmaceutical and research company with facilities in countries around the world, including Belgium, France, Japan, Mexico, the Netherlands, and the United Kingdom, among others. The company’s headquarters is located in New York City. BMS lists its mission as “to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.”

• Bristol Myers Squibb Co Company Profile - Bristol Myers Squibb Co Overview - GlobalData

  Bristol-Myers Squibb Co (BMS) is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes, and commercializes biopharmaceutical products. The company offers its products in therapy areas such as oncology, hematology, immunology, cardiovascular, and neuroscience. It also engages in co-development, co-commercialization, licensing, or joint venture arrangements with third parties to develop specific drugs. BMS distributes its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies through brands such as Opdivo, Reblozyl, Krazati, Sprycel, and Sotyktu, among others. It operates manufacturing units in the US, Switzerland, Puerto Rico, Ireland, and the Netherlands. BMS is headquartered in [...] Gain a 360-degree view of Bristol-Myers Squibb Co and make more informed decisions for your business Gain a 360-degree view of Bristol-Myers Squibb Co and make more informed decisions for your business Learn more Headquarters United States of America Address Route 206 and Province Line Road, Princeton, New Jersey, 08543 Website www.bms.com Telephone 1 609 2524621 No of Employees 32,500 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange BMY (NYSE) Revenue (2024) $48.2B -0.2% (2024 vs 2023) EPS XYZ Net Income (2024) XYZ 178.8% (2024 vs 2023) Market Cap\ $125.5B Net Profit Margin (2024) XYZ 179.0% (2024 vs 2023) \ As of and is in US$ View Bristol-Myers Squibb Co financials ## Signals available in Bristol-Myers Squibb Co report Deal Volume 38

• Bristol Myers Squibb

  Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious

• Bristol-Myers Squibb Company | Pharmaceuticals, Biopharmaceuticals & Biotechnology | Britannica Money

  The original firm, Clinton Pharmaceutical Co., was founded in Clinton, N.Y., in 1887 by William McLaren Bristol, Sr., and John R. Myers. It was incorporated as Bristol-Myers Company in 1900 and by then had moved from Clinton to Syracuse and then to Brooklyn. The company first made drugs for physicians, but after World War I it concentrated on the laxative Sal Hepatica and other over-the-counter proprietary drugs and entered the field of toiletries, notably with Ipana toothpaste. In 1929 Bristol-Myers was absorbed by a giant holding company, Drug Inc., which, however, dissolved during the Great Depression. Bristol-Myers became a publicly traded company in 1933. [...] In addition to over-the-counter products such as Excedrin analgesics and Enfamil infant formulas, Bristol-Myers Squibb both manufactures and distributes prescription medications for the treatment of diseases such as cancer, diabetes, and hypertension. This article was most recently revised and updated by Jeannette L. Nolen. [...] Market cap: : $128.41 bil. Annual revenue: : $49.19 bil. Earnings per share (prev. year): : $4.54 Sector: : Health Care Industry: : Pharmaceuticals CEO: : Dr. Christopher S. Boerner Ph.D. Headquarters: : New York City News • Bristol Myers sues Amgen over proposed Opdivo biosimilar • (Reuters) Bristol-Myers Squibb Company, American biopharmaceutical company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887. It produces pharmaceuticals, vitamins, medical devices, and beauty and personal-care products. Headquarters are in New York City.

• BMY: Bristol-Myers Squibb Company - Stock Price, Quote and News - CNBC

  Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene... Christopher Boerner Ph.D. Chairman of the Board, Chief Executive Officer David Elkins Executive Vice President, Chief Financial Officer, Member of the Leadership Team Wendy Bartie Executive Vice President, Corporate Affairs, Member of the Leadership Team Cari Gallman